Clinical TCP data for prostate cancer indicate proton RBE declines modestly with rising dose per fraction yet stays near the nominal value of 1.1.
Proton therapy for prostate cancer: A review of rationale, evidence, and current state
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
physics.med-ph 1years
2023 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response
Clinical TCP data for prostate cancer indicate proton RBE declines modestly with rising dose per fraction yet stays near the nominal value of 1.1.